Donald Trump and the GOP must seize on common-sense healthcare reforms that bring down Americans’ costs without strangling innovation.

Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with ...

“This project is about using AI to automate and improve the early stages of drug development, particularly antibody design,” ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...

One of the projects supported by that funding is showing real promise: a new drug discovered by Ohio State University ...

The pharmaceutical industry is undergoing a transformative shift fueled by data analytics. As drug development becomes increasingly complex, analytics is emerging as a key enabler of innovation and ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma treatment VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis ...

Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic ...

The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?